Michelle J. Hickey

Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis.

Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system.

Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors.

siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.

FAPP2 gene downregulation increases tumor cell sensitivity to Fas-induced apoptosis.

Cellular and vaccine therapeutic approaches for gliomas.

Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas.

Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy.

Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response.

Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain.

Combining cellular and gene therapy approaches for treatment of intracranial tumors.

Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.